Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of SCGB2A2 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Rabbit |
| Applications | IP,ELISA,WB-Ce,IHC-P |
More info about SCGB2A2 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB12703 |
| Product name: | SCGB2A2 polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of SCGB2A2. |
| Immunogen: | A synthetic peptide corresponding to internal region of human SCGB2A2. |
| Form: | Liquid |
| Recommend dilutions: | Western Blot (0.1-1 ug/mL) ELISA (0.01-0.1 ug/mL) Immunoprecipitation (2-5 ug/mL) Immunohistochemistry (0.5-2 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In TBS, pH 7.2 (BSA, 10% Proclin300) |
| Storage instruction: | Store at 4°C. For long term storage store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. |
| Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Specificity: | This antibody only recognizes ~10 KDa of human SCGB2A2. |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | The cell lysate derived from MCF-7 was immuno-blotted by SCGB2A1 polyclonal antibody (Cat # PAB12703) at 1 : 500. |
| Applications: | IP,ELISA,WB-Ce,IHC-P |
| Shipping condition: | Dry Ice |
| Publications: | Mammaglobin B gene as a novel marker for lymph node micrometastasis in patients with abdominal cancers.Aihara T, Fujiwara Y, Miyake Y, Okami J, Okada Y, Iwao K, Sugita Y, Tomita N, Sakon M, Shiozaki H, Monden M. Cancer Lett. 2000 Mar 13;150(1):79-84. |